21 May 2009
Short term prognosis of patients with refractory heart failure and atrial fibrillation qualified for heart transplantation – POLKARD HF
M Sobieszczańska-Małek, T Zieliński, M Piotrowska, G Religa, A Browarek, J Różański, J KorewickiAnn Transplant 2009; 14(1): 33-33 :: ID: 880316
Abstract
Background: Atrial fibrillation (AF) is the most common arrhythmia in patients (pts) with heart failure, which significantly influences survival. Aim of the study: to assess prognosis of pts with refractory heart failure (rHF) qualified for heart transplantation (HTX).
Material/Method: 872 pts (107 W and 765 M) were qualified for HTX between Jan 2003 and Nov 2007. The end points of the study were: death or HTX (UNOS 1), the end of observation: death or HTX. 680 pts were on sinus rhythm (SR) and 192 (22.0%) had atrial fibrillation (AF). During follow up (1-1601days, mean 461 days) 155 pts (17.7%) died, 17.6% with SR and 18.2% with AF (ns). EF - mean 21.6 (SR) and 21.8 (FA), NYHA 3.1 (SR), NTproBNP - mean 3635.4 (SR) and 4349.4 (FA), Arronson - mean 7.8 (SR) and 7.7 (FA). There were no significant differences between groups. We analyzed influence of heart rate (Kaplan-Maier method) on survival. The pts were divided according to HR: gr. I - <70/min, gr. II 71-89/min, gr. III >90/min. The shortest survival rate was noticed in group III. There was no difference in survival between group I and II.
Conclusions: Aatrial fibrillation was not a significant death risk factor among patients waiting for HTX. Heart rate >90/min connects with worse prognosis in patients waiting for HTX.
Keywords: Heart Transplantation
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860